Achillestendinopathy Treated With Proximal Medial Gastrocnemius Recession
Launched by OSTFOLD HOSPITAL TRUST · Dec 16, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a surgical procedure called Proximal Medial Gastrocnemius Recession, aimed at treating chronic pain in the Achilles tendon, specifically for patients with a condition known as Chronic Mid-Portion Achilles Tendinopathy. The trial will follow 60 patients over five years to see how well this surgery helps relieve their pain and improve their ability to walk and be active.
To be eligible for this study, participants must be between 18 and 75 years old and have been experiencing pain in the middle part of their Achilles tendon for at least a year. They should also have tried physical therapy without finding relief. A doctor will need to confirm their condition through a physical exam and an MRI, which is a special scan that shows detailed images of the tendon. Patients who have had previous serious injuries or surgeries on their Achilles tendon, or other significant health issues, may not qualify. Those who participate can expect to have their progress monitored for five years after the surgery, providing valuable information about the long-term benefits of this treatment.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • 1. Age 18-75 years.
- • 2. Diagnosis CMPAT verified clinically by orthopedic surgeon. Symptoms must include mid-portion pain in the Achilles, swelling and reduced tolerance for weightbearing.
- • 3. Verified diagnosis with MRI findings representing pathologic processes of tendon degeneration and repair (13). MRI no older than 12 months.
- • 4. Duration of symptoms must be at least 12 months.
- • 5. Isolated gastrocnemius tightness must be verified with the Silfverskiölds test before inclusion. The Silfverskiöld test is considered positive if ankle dorsiflexion is restricted to 5 degrees or less with the knee extended, and there is an increase of ankle dorsiflexion of at least 10 degrees when flexing the knee.
- • 6. At least three months of conventional physical therapy with eccentric training must have been tried without providing relief of symptoms.
- Exclusion criteria:
- • 1. Previous history of complete Achilles tendon rupture.
- • 2. Other combined pathologies in the Achilles tendon of calf (Sequela from trauma, infections, cancer etc.).
- • 3. Insertional Achilles tendinopathy.
- • 4. Previously undergone surgery in affected tendon.
- • 5. Patients with severe talocrural pathology or serious malalignment of foot and ankle.
- • 6. Severely reduced peripheral circulation.
- • 7. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent.
- • 8. Patients with a contraindication/non-compliance for MRI examination.
- • 9. History of allergic reaction/anaphylactic reaction to local anesthetics.
- • 10. Not able to read and/or speak a Scandinavian language or English adequately.
- • 11. Other serious comorbidity that makes surgery unadvisable.
About Ostfold Hospital Trust
Østfold Hospital Trust is a leading healthcare institution in Norway, dedicated to providing high-quality medical care and advancing clinical research. With a commitment to innovation and patient-centered practices, the trust facilitates a wide range of clinical trials aimed at improving treatment outcomes and enhancing healthcare delivery. By collaborating with multidisciplinary teams and leveraging state-of-the-art facilities, Østfold Hospital Trust plays a pivotal role in contributing to medical knowledge and improving the health of the communities it serves. Its focus on ethical standards and rigorous scientific methodology ensures that all research activities uphold the highest quality and safety standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sarpsborg, østfold, Norway
Sarpsborg, , Norway
Oslo, , Norway
Patients applied
Trial Officials
Marius Molund, PhD
Principal Investigator
Ostfold Hospital Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials